Ajes Pharmaceuticals Private Limited
About Ajes Pharmaceuticals Private Limited
Data last updated:
Ajes Pharmaceuticals Private Limited is a private limited company based in Bhopal, Madhya Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 27 December 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U52311MP2011PTC027383. Its GSTIN is 23AAKCA1230B1ZK (Madhya Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Arun Sharma and Anupama Sharma.
Its last annual general meeting (AGM) was held on 25 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bunglow – 10 Sanyukta Suresh Vihar Chunabhatti, Bhopal, Madhya Pradesh, India – 462001.
As per the financials filed for FY 2025, the company reported a revenue of ₹18.87 Lakh, a decline of 2% compared to the previous year. For the same year it recorded a net profit of ₹1.25 Lakh (net margin 6.6%) and EBITDA of ₹1.25 Lakh (EBITDA margin 6.6%). Revenue has grown at a compounded annual rate (CAGR) of 53% over three years and 44% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Ajes Pharmaceuticals Private Limited's registered office is in Bhopal, Madhya Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressBunglow – 10 Sanyukta Suresh Vihar Chunabhatti, Bhopal, Madhya Pradesh, India – 462001
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Ajes Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ajes Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Ajes Pharmaceuticals Private Limited, buy the company report.
Financials of Ajes Pharmaceuticals Private Limited
FY 2025 filings availableAjes Pharmaceuticals Private Limited reported revenue of ₹18.87 Lakh (down 2% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 2% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 44%. EBITDA fell 2% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.25 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.25 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.6% | ||||
| Net Profit Margin | 6.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ajes Pharmaceuticals Private Limited, buy the company report.
Board of directors of Ajes Pharmaceuticals Private Limited
Ajes Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Arun Sharma | Director | 27 Dec 2011 | 14 Years 10 Months | Current |
| Anupama Sharma | Director | 27 Dec 2011 | 14 Years 10 Months | Current |
Auditor
Ajes Pharmaceuticals Private Limited is audited by PATEL VARMA & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PATEL VARMA & ASSOCIATES | FY 2023 | 009108C |
Shareholding
The shareholding of Ajes Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Ajes Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Ajes Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ajes Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Ajes Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAKCA1230B1ZK | Madhya Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Ajes Pharmaceuticals Private Limited, buy the company report.
Recent activity
Ajes Pharmaceuticals Private Limited has 2 board changes on record since 2011: 2 appointments. The latest: Anupama Sharma was appointed as Director on 27 Dec 2011.
Frequently asked questions
Ajes Pharmaceuticals is an active private limited company based in Bhopal, Madhya Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 27 December 2011 (15+ years old) and is registered under CIN U52311MP2011PTC027383.
Ajes Pharmaceuticals has 2 current directors:
- Arun Sharma - Director
- Anupama Sharma - Director
The latest financial statements of Ajes Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 25 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Ajes Pharmaceuticals is 23AAKCA1230B1ZK, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Ajes Pharmaceuticals is U52311MP2011PTC027383. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ajes Pharmaceuticals was incorporated on 27 December 2011, making it 15+ years old. It is registered with the Registrar of Companies, Gwalior.
Anupama Sharma was appointed as Director on 27 Dec 2011. Arun Sharma was appointed as Director on 27 Dec 2011.
The registered office of Ajes Pharmaceuticals is at Bunglow – 10 Sanyukta Suresh Vihar Chunabhatti, Bhopal, Madhya Pradesh, India – 462001.
Ajes Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Ajes Pharmaceuticals is compliant as of 10 September 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
